Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nano-X Imaging (NNOX) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Nano-X Imaging (NNOX) over the last 6 years, with Q3 2025 value amounting to $19.4 million.

  • Nano-X Imaging's Total Liabilities fell 337.09% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year decrease of 337.09%. This contributed to the annual value of $20.9 million for FY2024, which is 973.03% down from last year.
  • Per Nano-X Imaging's latest filing, its Total Liabilities stood at $19.4 million for Q3 2025, which was down 337.09% from $20.7 million recorded in Q2 2025.
  • In the past 5 years, Nano-X Imaging's Total Liabilities ranged from a high of $71.0 million in Q4 2021 and a low of $55448.0 during Q2 2022
  • Moreover, its 5-year median value for Total Liabilities was $20.6 million (2024), whereas its average is $22.3 million.
  • In the last 5 years, Nano-X Imaging's Total Liabilities plummeted by 9941.72% in 2022 and then skyrocketed by 5643946.04% in 2023.
  • Nano-X Imaging's Total Liabilities (Quarter) stood at $71.0 million in 2021, then plummeted by 47.55% to $37.3 million in 2022, then plummeted by 37.9% to $23.1 million in 2023, then dropped by 9.73% to $20.9 million in 2024, then decreased by 7.21% to $19.4 million in 2025.
  • Its Total Liabilities stands at $19.4 million for Q3 2025, versus $20.7 million for Q2 2025 and $19.6 million for Q1 2025.